Noraxon myoRESEARCH™ Software Gait Analysis Evaluation and Orthotic Gait Correction in Reducing Diabetic Foot Ulceration Or Subsequent Amputation in Patients With a History of a Diabetic Foot Ulceration (NECRO)
Status
Conditions
Treatments
Details and patient eligibility
About
Determining whether the utilization of Noraxon myoRESEARCH Software gait analysis Evaluation and orthotic gait Correction can reduce diabetic foot ulceration Or subsequent amputation in patients with a history of a diabetic foot ulceration.
Full description
The purpose of this study is to identify emerging abnormal structural pathology of the vulnerable re-ulcerative diabetic foot incorporating physical therapy evaluation as well as the Noraxon gait analysis to generate quantitative and qualitative gait data. Once peak foot pressures and gait pathology is identified, gait remedy is fabricated including either a foot orthotic and/or an ankle foot prosthesis. Evaluation of constructed remedy will then be evaluated focusing on gait analysis data to validate decreased plantar foot peak pressures and gait realignment towards the reduction of the diabetic foot re-ulceration and subsequent foot or limb loss.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- History of healed diabetic foot ulceration
- Over 18 years of age
Exclusion criteria
Patients who are:
- under 18 years of age
- non-diabetic
- non-ambulatory
- non-healed wounds.
Trial design
Primary purpose
Allocation
Interventional model
Masking
69 participants in 1 patient group
Trial contacts and locations
Loading...
Central trial contact
Priscilla Frost-Larity
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal